A technique for assay of lecithinase antibodies in serum was developed in this laboratory by using a lecithin-agar plate diffusion procedure based on a combination of described plate assays. Egg yolk lipoprotein composed primarily of lecithin was used as a substrate for reaction with free or non-neutralized lecithinase C after incubation of known amounts of lecithinase C with various dilutions of control and test sera. It was found that the size of the reaction zone was a function of enzyme concentration and inversely proportional to the antibody concentration. Accuracy and precision of the assay were determined. In addition, lecithinase antibody levels in sera from experimentally inoculated rats and rabbits and sera from randomly selected human patients were studied.
A technique for assay of lecithinase antibodies in serum was developed in this laboratory by using a lecithin-agar plate diffusion procedure based on a combination of described plate assays. Egg yolk lipoprotein composed primarily of lecithin was used as a substrate for reaction with free or non-neutralized lecithinase C after incubation of known amounts of lecithinase C with various dilutions of control and test sera. It was found that the size of the reaction zone was a function of enzyme concentration and inversely proportional to the antibody concentration. Accuracy and precision of the assay were determined. In addition, lecithinase antibody levels in sera from experimentally inoculated rats and rabbits and sera from randomly selected human patients were studied.
The absence of a satisfactory assay method for detection of lecithinase antibodies in microquantities of serum led to the development of a lecithin-agar plate diffusion test. This test was based on a combination of the agar diffusion plate method for assay of lecithinase from Clostridiwn perfringens of Sheldon et al. (7) and the plate method for antibiotic assay of clinical specimens of Bennett et al. (2) .
Accurate determination of antibody titers in such a system requires application of the principle that a linear relationship occurs between the square of zone diameters and antigen concentration (1) . However, to facilitate calculation, the linecar portion of the standard curve may be utilized for calculation of test results directly.
MATERIALS AND METHODS Diluent. Borate-buffered saline (pH 7. 3) was prepared by addition of 10.94 g of boric acid, 1 Determination of optimal lecithinase C concentration. Lecithinase C concentrations to be employed were determined by preparing serial two-fold dilutions of lecithinase C in diluent. Since the initial concentration was 2,000 jsg of lecithinase C per ml of diluent (w/v), final concentrations of 3.65 ,ug/ml to 1,000 ,ug of lecithinase C per ml of diluent were (ii) The standards were preparedas shown inTablel. Test preparations. Standard curves were run by using 500 jag of lecithinase C per ml as determined (see above). An equal volume of lecithinase C was added to each tube containing 1 ml of the diluted antibody solution used in the standard curve. After 15 min of incubation, 0.04 ml of each mixture was added to each of five replication wells on the lecithinagar plate (see Fig. 1 ).
Calculation of the standard curve and unknowns. (Note: b must be negative since zone decreases as antibody increases.)
The y intercept is a = E (7)/25 -0.8 b.
Confidence limits may be calculated for predicted concentrations corresponding to observed mean zone diameters of unknown sera (4) . In a typical assay, 95% confidence limits were calculated for the predicted concentrations corresponding to the given observed mean zone diameters where each mean is based on three observations. In this assay, the precision was shown in Table 2 . Estimation of accuracy of the assay. To determine the accuracy of the test, antisera containing known amounts of a-antitoxin activity (C. perfringens type A, C, and D antisera) were diluted to contain 1.0, 0.8, and 0.6 units of activity per ml and tested in the plate assay. The zones of flocculation were measured and the antilecithinase activity was calculated as for unknown sera.
Determination of assay reliability. Two lecithinagar plates were prepared from the same preparation of diluent, agar, and egg on the same day. Dilutions of antibody for the standard curve were made by two of the co-authors. Using the independently prepared dilutions, one investigator prepared five standard curves and the other four, each operator using one of the two plates. Plates were incubated under identical conditions and were read after 21 hr of incubation. This procedure permitted us to make statistical comparisons of differences between the standard curves of the same operator as well as between operators.
Development of antilecithinase activity in rats and rabbits injected with lecithinase C. Norwegian hooded rats and New Zealand white rabbits were injected with increasing amounts of lecithinase C. Rats were injected intraperitoneally 11 times with the material in increasing amounts from 40 to 1,500 ,g, and rabbits were injected subcutaneously 6 times with the material in increasing amounts from 40 to 1,500 ,ug and with two intraperitoneal injections of 1,500 Ag each. Animals were bled and their sera were tested weekly. Deternination of lecithinase antibody levels in 231 human sera. Lecithinase antibody determinations were made in 231 sera obtained from two commercial 
RESULTS
A typical lecithin-agar assay plate after 20 hr incubation at 37 C is presented in Fig. 1 . in diameter and to develop "fuzzy" margins that tended to merge with adjoining zones. Incubation time (approximately 20 hr) was chosen as a matter of convenience, and we made no attempt to measure the rate of increase in zone diameters. Antibody concentrations of 0 to 1.6 units/ml yielded a quadratic curve. Between 0.4 and 1.2 units/ml, the curve was substantially linear (Fig. 2) .
The accuracy of the assay as determined by "recovery" experiments was satisfactory (Table  4) . Recoveries ranged from 73 to 120%, with the majority of results falling between 90 and 110%. It should be noted that the poorest results occurred when type A antiserum, having the highest antibody concentration, was used. In this case, there was a large dilution factor of the order of 390:1 (diluent:antibody) so that minor errors in pipetting sera and diluent were magnified. The reliability of the assay based on a comparison of Eight rats and 7 rabbits immunized with increasing amounts of lecithinase C showed typical response curves (Fig. 3) . All rabbits had titers of more than 15 units/ml by the 14th day, and all rats but one had titers of 5 units/ml or more. The potency of lecithinase C preparation was such that three rabbits with titers of less than 25 units/ ml died when injected with 1,000 ,ug of lecithinase C subcutaneously. Similarly, two rats with antibody titers below 20 units/ml injected with 400 ,ug of lecithinase C intraperitoneally died.
Assays of 183 human sera from Laboratory A (Table 6) showed 92.3% with less than 4 units/ ml of lecithinase antibody, whereas 85.4% of sera from Laboratory B had less than 4 units/ml. The difference is not statistically significant. DISCUSSION The agar diffusion assay reported herein is an indirect but accurate and reproducible method for determination of antilecithinase activity in serum. Microquantities of sera can be assayed so that capillary blood specimens would be satisfactory. A 1:10 dilution will permit titration of most sera on a one-test basis. Dilution of sera also diminishes or eliminates possible errors due to endogenous lecithinase that may be present in some sera, e.g. in serum from patients on heparin therapy (3) .
The linear form of the standard curve appears to depend on the narrow range of antibody concentration used-0.4 to 1.2 units/ml. If the range is increased to 0 to 1.6 units/ml, the curve becomes quadratic, flattening out between 0 and 0.4 units/ ml and dropping sharply at concentrations higher than 1.2 units/ml (Fig. 2) . This is apparently due to the kinetics of diffusion in agar and because of the cylindrical geometry of the agar wells and their surrounding cloudy zones. Becker (1) has studied this and has demonstrated a linear relationship between the square of zone diameters and antigen concentration. We agree with Becker's interpretation, but fitting the standard curve and calculation of precision is far simpler when using the narrow range of antibody concentrations. In the average laboratory, it may be more satisfactory to redilute sera that are out-of-range until zone diameters fall in the linear portion of the curve.
The test worked well in measuring increasing antibody levels in rats and rabbits (Fig. 3) . The antibody ranges are wide as compared between animals, but we attribute this to differences in individual animal tolerance to highly toxic lecithinase C. The assay was used to determine antibody concentration in rat and rabbit sera prior to inoculation with additional lecithinase C. When animals were injected with amounts of lecithinase larger than the titers indicated they could tolerate, severe local reactions, bleeding, and death followed. We have found the assay useful in the measurement of rising antibody concentrations in rat serum during feeding of pure cultures of several strains of C. perfringens (to be published).
Slightly more than 9% of sera obtained from Laboratories A and B had more than 4 units/ml of lecithinase antibody. Since clinical histories were not obtained, we cannot report whether this reflects prior exposure to C. perfringens or its toxins. We conclude that 4 units/ml is the lower limit of sensitivity of the assay; the data (Table  6 ) also cautiously suggest that more than 8 units/ ml may indicate (i) exposure either to C. perfringens or its toxins or (ii) the presence of antibody to other lecithinase(s) that cross-react with lecithinase C. Samples with 4.0 to 7.9 units/ml may represent individuals with previous exposure to toxin; however, until studies can be made on samples from patients with known clostridial infection exact limits cannot be established.
